Abstract
There are few data on the role of lipid lowering in the primary prevention of coronary heart disease (CHD) in diabetic patients. This paper describes the design of a collaborative clinical trial between Diabetes UK, the NHS Research and Development Directorate and Pfizer UK, that addresses this question.
Original language | English |
---|---|
Pages (from-to) | 201-211 |
Number of pages | 11 |
Journal | Diabetic Medicine |
Volume | 19 |
Issue number | 3 |
DOIs | |
Publication status | Published - Mar 2002 |